ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate

Completed · Phase 2 · Has a placebo group

Conditions studied: Rheumatoid Arthritis

In brief

This study is evaluating the safety, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of ACP-196 in subjects with Rheumatoid Arthritis on background Methotrexate.

Key facts

Study ID: NCT02387762
Run by: Acerta Pharma BV
People needed: 31
Starts: 2015-04-01
Expected to finish: 2016-06-01
Last updated by the study team: 2019-04-02

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Pinnacle Research Group — Anniston, Alabama, United States
Achieve Clinical Research — Birmingham, Alabama, United States
Advanced Arthritis Care and Research — Scottsdale, Arizona, United States
TriWest Research Associates, LLC — El Cajon, California, United States
Neuropsychiatric Research Center of Orange County — Orange, California, United States
Pacific Arthritis Center Medical Group — Santa Monica, California, United States
Inland Rheumatology and Osteoporosis Medical Group, Inc — Upland, California, United States
San Marcus Research Clinic, Inc. — Hialeah, Florida, United States
Suncoast Clinical Research, Inc. — New Port Richey, Florida, United States
Suncoast Clinical Research — New Port Richey, Florida, United States
The Arthritis Center — Palm Harbor, Florida, United States
Office of George Timothy Kelly, MD — Las Vegas, Nevada, United States
PMG Research of Salisbury — Salisbury, North Carolina, United States
Health Research of Oklahoma — Oklahoma City, Oklahoma, United States
Altoona Center for Clinical Research — Duncansville, Pennsylvania, United States
Ramesh C. Gupta, MD — Memphis, Tennessee, United States
Clear Lake Regional Medical Center — Webster, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.